Polypharmacy in the elderly when good drugs lead to bad outcomes: a teachable moment. | AHRQ Patient Safety Network

Polypharmacy in the elderly when good drugs lead to bad outcomes: a teachable moment. | AHRQ Patient Safety Network

• Commentary
 
• Published April 2017

Polypharmacy in the elderly—when good drugs lead to bad outcomes: a teachable moment.

Carroll C, Hassanin A. JAMA Intern Med. 2017 Apr 24; [Epub ahead of print].

Geriatric patients are particularly vulnerable to adverse drug events due to comorbidities, complicated care plans, and polypharmacy. This commentary describes how using STOPP criteria and performing indication mapping can help reduce polypharmacy and improve patient safety.

PubMed citationAvailable at

Related Resources

WEB RESOURCE › MULTI-USE WEBSITE

Medication Without Harm: WHO's Third Global Patient Safety Challenge.

Geneva, Switzerland: World Health Association.

JOURNAL ARTICLE › STUDY

30-day potentially avoidable readmissions due to adverse drug events.

Dalleur O, Beeler PE, Schnipper JL, Donzé J. J Patient Saf. 2017 Mar 17; [Epub ahead of print].

NEWSPAPER/MAGAZINE ARTICLE

Medication errors attributed to health information technology.

Lawes S, Grissinger M. PA-PSRS Patient Saf Advis. March 2017;14:1-8.

JOURNAL ARTICLE › STUDY

Pediatric prehospital medication dosing errors: a national survey of paramedics.

Hoyle JD Jr, Crowe RP, Bentley MA, Beltran G, Fales W. Prehosp Emerg Care. 2017;21:185-191.

JOURNAL ARTICLE › STUDY

Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database.

Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Pharmacoepidemiol Drug Saf. 2017 Feb 24; [Epub ahead of print].

View More